Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes of Members' Deficit/Shareholders' Equity

v3.21.1
Condensed Statements of Changes of Members' Deficit/Shareholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Members Interests
Nonvoting Common Stock
Accumulated Deficit
Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss       $ (466,553) $ (466,553)
Beginning Balance at Dec. 31, 2019     $ 12,601,201 (17,618,710) (5,017,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss       (466,553) (466,553)
Ending Balance at Mar. 31, 2020     $ 12,601,201 (18,085,263) (5,484,062)
Balances, Beginning at Dec. 31, 2020 $ 830 $ 57,905,164   (27,965,105) 29,940,889
Balances, Beginning (in shares) at Dec. 31, 2020 8,305,075        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   24,825     24,825
Exercise of warrants $ 3 197,559     197,562
Exercise of warrants (in shares) 25,315        
Net loss       (3,056,033) (3,056,033)
Balances, Ending at Mar. 31, 2021 $ 833 $ 58,127,548   (31,021,138) 27,107,243
Balances, Ending (in shares) at Mar. 31, 2021 8,330,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss       $ (3,056,033) $ (3,056,033)